CN104273612A - 一种甘蔗生物型饮品 - Google Patents
一种甘蔗生物型饮品 Download PDFInfo
- Publication number
- CN104273612A CN104273612A CN201410588791.4A CN201410588791A CN104273612A CN 104273612 A CN104273612 A CN 104273612A CN 201410588791 A CN201410588791 A CN 201410588791A CN 104273612 A CN104273612 A CN 104273612A
- Authority
- CN
- China
- Prior art keywords
- sugarcane
- drink
- juice
- black tea
- sugar cane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000000111 Saccharum officinarum Species 0.000 title claims abstract description 95
- 235000007201 Saccharum officinarum Nutrition 0.000 title claims abstract description 95
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 33
- 244000269722 Thea sinensis Species 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 17
- 235000020279 black tea Nutrition 0.000 claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 235000019225 fermented tea Nutrition 0.000 claims description 30
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical compound CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 16
- 230000001580 bacterial effect Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 239000003905 agrochemical Substances 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 241000233866 Fungi Species 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 235000013616 tea Nutrition 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 230000008821 health effect Effects 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000235342 Saccharomycetes Species 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 244000119012 Bequaertiodendron magalismontanum Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
一种甘蔗生物型饮品。具体包括：以甘蔗为主要原料制备甘蔗汁液，然后再以甘蔗汁液为培养基，用红茶菌为菌源，制备出新型特色的甘蔗红茶菌生物型饮品。通过实施本发明，将甘蔗和红茶菌有机结合起来，所组合起来的营养物质更加丰富；甘蔗和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯用甘蔗制成的饮品及传统的红茶菌饮料。同时，所制备出来的甘蔗茶菌饮品口感酸甜适口，适口性非常好，适用人群极为广泛，是一种兼备饮料及有医药功效的双重功能生态保健饮品，市场前景非常好。
Description
技术领域
本发明属于一种功能性水果型饮品的制备技术领域，具体涉及一种甘蔗生物型饮品。
背景技术
甘蔗是水果中唯一的茎用水果，也是水果中含纤维(包括非膳食纤维)最多的一种水果。甘蔗汁多味甜，营养丰富，被称作果中佳品，有人称：“秋日甘蔗赛过参”。甘蔗的营养价值很高，它含有水分比较多，水分占甘蔗的84％。甘蔗含糖量最为丰富，其中的蔗糖、葡萄糖及果糖，含量达12％。此外，甘蔗还含有对人体新陈代谢非常有益的各种维生素、脂肪、蛋白质、有机酸、钙、铁等物质，如蛋白质0.2克、脂肪0.5克、钙8毫克、磷4毫克、铁1.3毫克。另外，甘蔗还含有天门冬氨酸、谷氨酸、丝氨酸、丙氨酸等多种有利于人体的氨基酸，以及维生素B1、维生素B2、维生素B6和维生素C等等。甘蔗的含铁量在各种水果中，雄踞“冠军”宝座。
我国古代医学家还将甘蔗列入“补益药”。中医认为，甘蔗入肺、胃二经，具有清热、生津、下气、润燥、补肺益胃的特殊效果。甘蔗可治疗因热病引起的伤津，心烦口渴，反胃呕吐，肺燥引发的咳嗽气喘。甘蔗还可以通便解结，饮其汁还可缓解酒精中毒。《本草纲目》言：甘蔗性平，有清热下气、助脾健胃、利大小肠、止渴消痰、除烦解酒之功效，可改善心烦口渴、便秘、酒醉、口臭，肺热咳嗽、咽喉肿痛等症。
目前，甘蔗主要是用以制糖以及当做水果生食。
发明内容
本发明的目的就是提供全新的一种甘蔗生物型饮品。具体包括：以甘蔗为主要原料制备甘蔗汁液，然后再以甘蔗汁液为培养基，用红茶菌为菌源，制备出新型特色的甘蔗红茶菌生物型饮品。
所述的红茶菌是以茶水、糖为原料，经醋酸菌、酵母菌和乳酸菌等多种微生物共同发酵而成的。其中，红茶菌菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。红茶菌还富含维生素C、维生素B等营养素，并含有多种对人体有益的微生物，因此能调节人体生理机能，促进新陈代谢，帮助消化，防止动脉硬化，抗癌，养生强身，成为一种盛行全世界的养生保健饮料。
红茶菌在中国流传应用已有150余年的历史，近些年国内外医学界应用红茶菌的实践表明，红茶菌能治疗多种慢性疾病，如高血压、动脉硬化、冠心病、糖尿病、便秘、痔疮、肥胖症、斑秃、白发、白内障、风湿性关节炎、胃炎、痢疾、贫血、核黄素缺乏等。
根据营养分析，红茶菌饮料主要营养成分及相应的功能如下：
(1)多糖、茶多酚、低聚异麦芽糖、茶碱：提高人体免疫力，增强自身抵抗力；调节血脂，调节血糖；促进双歧杆菌生长，减少肠道腐败物质和致癌物质；增加T-淋巴细胞和B-淋巴细胞的数量，提高机体的防御能力。
(2)醋酸、乳酸、柠檬酸：清理肠胃，帮助消化，防治便秘，提高维生素的稳定性，预防有害病菌、病毒入侵，预防感冒。
(3)咖啡因：提高大脑活力，消除疲劳，振作精神。
(4)红茶菌中含有三种对人体有益的益生菌：酵母菌，醋酸菌和乳酸菌。对人体可起到特殊的保健作用。
(5)清理肠胃，消毒解毒，通畅大便，杀灭有害病菌，增加有益菌落，适用于急慢性胃炎，肠炎，便秘，顽固性便秘消除，顽固性腹泻，痢疾等痊愈。
(6)调理肠胃，食欲不振这增加饮食，饭量大增，营养不良者可恢复健康，特别是可使城乡最常见最难治的胃溃疡，十二指肠胃溃疡，胃下垂等胃病痊愈，反胃，呕吐，反酸水等症状消失。
(7)现代医学证明，醋酸具有消除疲劳、增强食欲、帮助消化、防治高血压和动脉硬化的作用，还具有一定的抗肿瘤、防肥胖，使钙易于被人体吸收、保持骨骼的柔韧以及润肌嫩肤的作用。
(8)肝脏障碍排除，急慢性肝炎、肝硬化痊愈。许多人认为红茶菌的解毒抗癌功能因子之一是葡萄糖醛酸，它是人体肝脏中最主要的解毒物质之一。
(9)红茶菌中存在的葡萄糖二酸1，4内酯可使肝素、透明质酸、硫酸粘多糖以及葡萄糖醛酸的破坏大大减少，帮助身体更有效地排出毒素，防癌抗癌，并缓解关节炎、痛风、气喘和相关组织功能下降所引起的其它不适。
(10)痔疮软化消失，更年期功能障碍减少。红茶菌中的葡萄糖酸能与重金属结合形成水溶性复合物，帮助人体排出有害的重金属元素。有研究表明新的红茶菌饮用者尿中的重金属含量增加。
本发明是通过以下技术方案来实现的：
一种甘蔗生物型饮品，技术方案中在于：以甘蔗为主要原料制备甘蔗汁液，然后再以甘蔗汁液为培养基，用红茶菌为菌源，制备出新型特色的甘蔗红茶菌生物型饮品。
1、所述的甘蔗汁液制备方法如下：
(1)原料选择：采集无病虫害、无农药残留、生长期是8个月以上、新鲜的甘蔗为原料；
(2)原料处理：将甘蔗的叶片剥干净，然后再清洗干净；
(3)打浆：将清洗干净的甘蔗按照常规方法打成浆汁；
(4)过滤：把上述浆汁经过过滤而得生产用甘蔗汁液。
2、所述的甘蔗红茶菌生物型饮品制备方法如下：
(1)原料组成及配比：甘蔗汁液100份、冷开水50份、红茶菌种3份；
(2)发酵：将上述甘蔗汁液、冷开水、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将甘蔗汁液发酵至溶液的PH为3.5～4.5而得成品甘蔗红茶菌生物型饮品。
本发明既有如下优点：
1、本发明所提出的一种甘蔗生物型饮品其制备方法不但构思新颖，而且加工工艺简单，容易实施。
2、实施本发明所用的主要原料——甘蔗，该原料资源十分丰富，而且容易组织，价格低廉。此外，甘蔗的营养价值很高，它含有水分比较多，水分占甘蔗的84％。甘蔗含糖量最为丰富，其中的蔗糖、葡萄糖及果糖，含量达12％。甘蔗还含有对人体新陈代谢非常有益的各种维生素、脂肪、蛋白质、有机酸、钙、铁等物质，如蛋白质0.2克、脂肪0.5克、钙8毫克、磷4毫克、铁1.3毫克。另外，甘蔗还含有天门冬氨酸、谷氨酸、丝氨酸、丙氨酸等多种有利于人体的氨基酸，以及维生素B1、维生素B2、维生素B6和维生素C等等。甘蔗的含铁量在各种水果中，雄踞“冠军”宝座。
3、制备本发明所用的菌源——红茶菌，该菌种具有培育方法简单、菌种形成周期短、生产成本低廉、菌种质量稳定等有点；同时，红茶菌中主要含有三种对人体特别有益的益生菌：酵母菌、醋酸菌和乳酸菌，对人体可起到特殊的保健作用；同时，由于红茶菌是用茶叶制备的茶液作为培养基，所以菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。因此，红茶菌不但富含有多种对人体有益的微生物，还含有多种营养物质，能调节人体生理机能、促进新陈代谢、帮助消化、防止动脉硬化、抗癌、养生强身等。
4、通过实施本发明，将甘蔗和红茶菌有机结合起来，所组合起来的营养物质更加丰富；甘蔗和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯用甘蔗制成的饮品及传统的红茶菌饮料。
5、通过实施本发明，所制备出来的甘蔗茶菌饮品口感酸甜适口，适口性非常好，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
6、通过实施本发明，制备而成的甘蔗茶菌饮料成本非常低，但由于该饮料营养丰富、保健效果好、物美价廉，适用人群极为广泛，所以市场前景非常好。
具体实施方式
下面结合实施例对本发明的方法进一步说明。
一种甘蔗生物型饮品，技术方案中在于：以甘蔗为主要原料制备甘蔗汁液，然后再以甘蔗汁液为培养基，用红茶菌为菌源，制备出新型特色的甘蔗红茶菌生物型饮品。
具体实施方式如下：
1、制备甘蔗汁液：
(1)原料选择：采集无病虫害、无农药残留、生长期是8个月以上、新鲜的甘蔗为原料；
(2)原料处理：将甘蔗的叶片剥干净，然后再清洗干净；
(3)打浆：将清洗干净的甘蔗按照常规方法打成浆汁；
(4)过滤：把上述浆汁经过过滤而得生产用甘蔗汁液。
2、制备甘蔗红茶菌生物型饮品：
(1)原料组成及配比：甘蔗汁液100份、冷开水50份、红茶菌种3份；
(2)发酵：将上述甘蔗汁液、冷开水、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将甘蔗汁液发酵至溶液的PH为3.5～4.5而得成品甘蔗红茶菌生物型饮品。
Claims (1)
1.一种甘蔗生物型饮品，其特征在于：以甘蔗为主要原料制备甘蔗汁液，然后再以甘蔗汁液为培养基，用红茶菌为菌源，制备出新型特色的甘蔗红茶菌生物型饮品；
所述的甘蔗汁液制备方法如下：
(1)原料选择：采集无病虫害、无农药残留、生长期是8个月以上、新鲜的甘蔗为原料；
(2)原料处理：将甘蔗的叶片剥干净，然后再清洗干净；
(3)打浆：将清洗干净的甘蔗按照常规方法打成浆汁；
(4)过滤：把上述浆汁经过过滤而得生产用甘蔗汁液；
所述的甘蔗红茶菌生物型饮品制备方法如下：
(1)原料组成及配比：甘蔗汁液100份、冷开水50份、红茶菌种3份；
(2)发酵：将上述甘蔗汁液、冷开水、红茶菌种放置在干净的塑料桶里，并将三种原料搅拌均匀，使红糖完全溶解于溶液之中，最后按照常规方法进行好氧发酵；
(3)成品：将甘蔗汁液发酵至溶液的PH为3.5～4.5而得成品甘蔗红茶菌生物型饮品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410588791.4A CN104273612A (zh) | 2014-10-28 | 2014-10-28 | 一种甘蔗生物型饮品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410588791.4A CN104273612A (zh) | 2014-10-28 | 2014-10-28 | 一种甘蔗生物型饮品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104273612A true CN104273612A (zh) | 2015-01-14 |
Family
ID=52249351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410588791.4A Pending CN104273612A (zh) | 2014-10-28 | 2014-10-28 | 一种甘蔗生物型饮品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104273612A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124034A (zh) * | 2015-08-13 | 2015-12-09 | 刘民钦 | 一种甘蔗红茶的制备方法 |
| CN106071564A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体制备虫草生物饮品 |
| CN106071565A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体培育桑黄生物饮品 |
| CN106071572A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体制备灵芝生物饮品 |
| CN106360172A (zh) * | 2016-08-29 | 2017-02-01 | 贺州学院 | 一种酵香型葛根马蹄甘蔗复合饮料的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
| JP2006333702A (ja) * | 2004-11-19 | 2006-12-14 | Yoshiaki Nagaura | 新しい抽出方法の発見 |
| CN103734838A (zh) * | 2013-12-27 | 2014-04-23 | 胡本奎 | 一种浓缩甘蔗汁的制作方法 |
-
2014
- 2014-10-28 CN CN201410588791.4A patent/CN104273612A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586328A (zh) * | 2004-10-11 | 2005-03-02 | 王�义 | 红茶菌饮料的生产方法 |
| JP2006333702A (ja) * | 2004-11-19 | 2006-12-14 | Yoshiaki Nagaura | 新しい抽出方法の発見 |
| CN103734838A (zh) * | 2013-12-27 | 2014-04-23 | 胡本奎 | 一种浓缩甘蔗汁的制作方法 |
Non-Patent Citations (1)
| Title |
|---|
| 蔡丽玲，等: ""红茶菌在绿茶2甘蔗汁培养液中培养条件的研究"", 《科技通报》, vol. 19, no. 3, 31 May 2003 (2003-05-31), pages 252 - 259 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105124034A (zh) * | 2015-08-13 | 2015-12-09 | 刘民钦 | 一种甘蔗红茶的制备方法 |
| CN106071564A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体制备虫草生物饮品 |
| CN106071565A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体培育桑黄生物饮品 |
| CN106071572A (zh) * | 2016-06-28 | 2016-11-09 | 黄秀英 | 一种以甘蔗汁为载体制备灵芝生物饮品 |
| CN106360172A (zh) * | 2016-08-29 | 2017-02-01 | 贺州学院 | 一种酵香型葛根马蹄甘蔗复合饮料的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104305427A (zh) | 葡萄红茶菌饮料 | |
| CN104304560A (zh) | 一种甜茶红茶菌 | |
| CN104382164A (zh) | 一种灵芝红茶菌 | |
| CN104304577A (zh) | 一种以金花茶为载体的生物型饮料及其制备方法 | |
| CN104336719A (zh) | 一种枸杞红茶菌饮料 | |
| CN104273271A (zh) | 一种荷花红茶菌饮料 | |
| CN104273612A (zh) | 一种甘蔗生物型饮品 | |
| CN104304578A (zh) | 一种火龙果菌茶 | |
| CN104287040A (zh) | 以百香果为原料制备生物型饮料 | |
| CN104351887A (zh) | 一种桑葚茶菌 | |
| CN104287046B (zh) | 一种以花生为主要原料的生物型饮料 | |
| CN104273613A (zh) | 一种芒果茶菌饮料 | |
| CN104304589A (zh) | 一种铁皮石斛茶菌 | |
| CN105614607A (zh) | 一种润肺止咳的保健饮料及制备方法 | |
| CN104273628A (zh) | 以薏米为原料的生物饮料及其制备方法 | |
| CN104382129A (zh) | 一种甜玉米红茶菌饮品 | |
| CN104351900A (zh) | 一种以糯米为原料的生物型饮料及其制备方法 | |
| CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
| CN104287045A (zh) | 一种大清枣茶菌饮品 | |
| CN104305429A (zh) | 一种发酵型黄秋葵茶饮料 | |
| CN104287044A (zh) | 一种猕猴桃红茶菌饮品 | |
| CN104304561A (zh) | 一种桑黄菌丝红茶菌饮料 | |
| CN104286280A (zh) | 一种木瓜红茶菌饮品 | |
| CN104432367A (zh) | 一种以墨米为原料的生物型饮料及其制备方法 | |
| CN105695287A (zh) | 一种富硒木耳桑葚保健黑醋 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150114 |
|
| RJ01 | Rejection of invention patent application after publication |